Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Point-of-care Test Based on Differential Leucocyte Count, Suitable for a Mass Screening Program to Detect SARS-CoV-2: A Diagnostic Accuracy Study

NCT04643860 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT04643860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04643860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Point-of-care Test Based on Differential Leucocyte Count, Suitable for a Mass Screening Program to Detect SARS-CoV-2: A Diagnostic Accuracy Study
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Withdrawn
Start date
January 15, 2021
Completion date
August 31, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection covid19